NeurAxis (NRXS) Proxy filing summary

Voting matters and shareholder proposals

• Election of six directors to serve until the next annual meeting or until successors are elected and qualified.

• Ratification of Rosenberg Rich Baker Berman, P.A. as independent auditor for the fiscal year ending December 31, 2026.

• Approval of an amendment to the 2022 Omnibus Securities and Incentive Plan to increase authorized shares from 1,482,152 to 3,400,000 and extend annual evergreen increases through January 1, 2033.

• Approval of the 2025 Employee Stock Purchase Plan.

Board of directors and corporate governance

• Six nominees are presented for election to the board: Beth Keyser, Bradley Mitch Watkins, Kristin Ferge, Gilad Aharon, Brian Carrico, and Christopher Robin Brown.

Executive compensation and say-on-pay

• Proposal to amend the 2022 Omnibus Securities and Incentive Plan, increasing share authorization and extending the evergreen provision, directly impacts executive and employee compensation incentives.

• Introduction of the 2025 Employee Stock Purchase Plan to further align employee interests with shareholders.